SHORT COMMUNICATION
Differences in GATA3 expression among histological/molecular subtypes and grades in infiltrating breast carcinoma (IBC) are important in the diagnosis of metastatic breast carcinoma
1
Department of Pathology, University of Medicine, Pharmacy, Sciences and Technology (UMFTS) of Târgu Mureş, Romania
2
Department of Pathology, Faculty of Medicine and Pharmacy, University of Oradea, Romania
Submission date: 2020-03-26
Acceptance date: 2020-03-30
Publication date: 2020-05-20
Pol J Pathol 2020;71(1):62-65
KEYWORDS
TOPICS
ABSTRACT
GATA-binding protein 3 (GATA3) is a sensitive and relatively specific marker in invasive breast carcinomas (IBC). The aim of the present study was to determine GATA3 expression among different histological and surrogate molecular breast carcinoma subtypes.
Immunohistochemical staining of ER, PR, Ki67, HER2 and GATA3 was performed in a cohort of 84 consecutive cases of primary IBCs. The association of GATA3 expression with different histological subtypes, grades and surrogate intrinsic molecular subtypes was assessed.
The overall positivity of GATA3 across various histological subtypes was 71.43% with no correlation with histological type (p = 0.849). Our study also confirmed that GATA3 exhibits a relatively high sensitivity for IBC (78.57%). GATA3 expression was positively correlated with low histological grades (G1/G2) vs. G3: p = 0.001) with most of G3 (57.89%) cases being negative and with luminal A (72.22%) and B (84.62%) subtypes (p = 0.00001) while most of the triple negative (87.5%) and HER2-overexpressed (66.67%) being negative.
Caution must be payed however when dealing with an IBC metastasis of HER2-overexpressed or triple negative molecular subtypes or G3, since in these categories according to the present study, GATA3 is more frequently negative that previously reported and may be useless for diagnosis of tumor origin.
Immunohistochemical staining of ER, PR, Ki67, HER2 and GATA3 was performed in a cohort of 84 consecutive cases of primary IBCs. The association of GATA3 expression with different histological subtypes, grades and surrogate intrinsic molecular subtypes was assessed.
The overall positivity of GATA3 across various histological subtypes was 71.43% with no correlation with histological type (p = 0.849). Our study also confirmed that GATA3 exhibits a relatively high sensitivity for IBC (78.57%). GATA3 expression was positively correlated with low histological grades (G1/G2) vs. G3: p = 0.001) with most of G3 (57.89%) cases being negative and with luminal A (72.22%) and B (84.62%) subtypes (p = 0.00001) while most of the triple negative (87.5%) and HER2-overexpressed (66.67%) being negative.
Caution must be payed however when dealing with an IBC metastasis of HER2-overexpressed or triple negative molecular subtypes or G3, since in these categories according to the present study, GATA3 is more frequently negative that previously reported and may be useless for diagnosis of tumor origin.
REFERENCES (9)
1.
Zhao M, Zhou L, Sun L, et al. GATA 3 is a sensitive marker for primary genital extramammary paget disease: an immunohistochemical study of 72 cases with comparison to gross cystic disease fluid protein 15. Diagnostic Pathol 2017; 12: 51.
2.
Guo Y, Yu P, Liu Z, et al. Prognostic and clinicopthologic value of GATA binding protein 3 in bresat carcer: a systematic review and meta-analysis. PLoS One 2017; 12: e0174843.
3.
Lu S, Yakirevich E, Wang LJ, et al. Cytokeratin 7-negative and GATA binding protein 3-negative breast cancers: clinicopathological features and prognostic significance. BMC Cancer 2019; 19: 1085.
4.
Shaoxian T, Baohua Y, Xiaoli X, et al. Characterisantion of GATA 3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes. J Clin Pathol 2017; 70: 926-934.
5.
Ni YB, Tsang JYS, Shao MM, et al. GATA-3 is superior to GCDFP-15 and mammaglobin to identify primary and metastatic breast cancer. Breast Cancer Res Treat 2018; 169: 25-32.
6.
Hafez NH, Shaaban HM. Can GATA3 immunohistochemistry be utilized as a reliable diagnostic marker for metastatic breast carcinoma in cytological material? A comparative study with Mammaglobin and GCDFP-15 expression. Turk Patholoji Derg 2018; 34: 143-149.
7.
El Hag MI, Hag AM, Ha JP, et al. Comparison of GATA-3, mammaglobin, GCDFP-15 expression in breast carcinoma in serous effusions: A cell-block micro-array study. Pleura Peritoneum 2017; 2: 143-148.
8.
Lakhani S, Ellis IO, Schnitt SJ, et al. WHO Classification of Tumours of the Breast. IARC press, Lyon 2012; 10-71.
9.
Amin MB, Edge SB, Greene FL, et al. (eds.). AJCC cancer staging manual. 8th edition 2017.
| eISSN: | 2084-9869 |
| ISSN: | 1233-9687 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
